Silver Book Fact

Every additional dollar spent on newer, less toxic hormonal therapy for breast cancer patients has produced health gains valued at between $27.03 and $36.81.

Murphy K, Topel R. The Value of Health and Longevity. National Bureau of Economic Research Working Paper. May-2005; 11405. http://www.nber.org/papers/W11405

Reference

Title
The Value of Health and Longevity
Publication
National Bureau of Economic Research Working Paper
Publication Date
May-2005
Authors
Murphy K, Topel R
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • After one year, 73 percent of non-small-cell lung cancer patients with the EGFR genetic mutation who were treated with a tyrosine kinase inhibitor had survived, compared to 15 percent who…  
  • Treating cancer patients with oral medicine versus intravenous chemotherapy results in a 2/3 reduction in hospital time and a greater than 50% reduction in costly medication side effects.  
  • An experimental drug may help those women whose breast cancer worsens despite use of other therapies. The medicine was shown in studies to nearly double the time breast cancer…  
  • According to the Pharmaceutical Research and Manufacturers of America, a medicine in development targets late-stage metastatic melanoma. The medicine contains a gene encoding antigen that may be able to…  
  • According to the Pharmaceutical Research and Manufacturers of America, a medicine currently in development may delay the worsening of liver cancer. The medicine is an oral signal transduction inhibitor…